|4Mar 3, 8:35 PM ET

Grimaud Brett A. 4

4 · Theravance Biopharma, Inc. · Filed Mar 3, 2023

Insider Transaction Report

Form 4
Period: 2023-03-01
Grimaud Brett A.
SVP, GEN COUNSEL AND SECRETARY
Transactions
  • Award

    Ordinary Shares

    2023-03-01+75,000304,958 total

Documents

1 file
  • 4
    form4-03042023_010337.xmlPrimary